Omnicell

Omnicell is a leading healthcare technology company specializing in medication management automation, pharmacy intelligence, and supply chain optimization for hospitals and health systems. Founded in 1992 and publicly traded on NASDAQ (OMCL), Omnicell serves over 7,000 facilities across the United States and internationally, including approximately 70% of the largest U.S. health systems.

The platform's core offering centers on its Autonomous Pharmacy vision—a fully integrated ecosystem designed to digitize and automate medication management from manufacturer to patient bedside. Omnicell's XT Series automated dispensing cabinets represent the hardware backbone, deployed across nursing units, operating rooms, and emergency departments to provide secure, point-of-care medication access with biometric authentication and real-time inventory tracking.

Omnicell's cloud-based intelligence platform leverages machine learning and predictive analytics to optimize pharmacy operations at scale. Key AI-driven capabilities include demand forecasting that analyzes historical dispensing patterns and census data to predict medication needs 72 hours in advance, diversion detection algorithms that identify anomalous controlled substance access patterns with reported 40% improvement in detection rates, and inventory optimization models that help reduce pharmaceutical waste by dynamically adjusting par levels across cabinet networks.

The EnlivenHealth division extends Omnicell's reach into retail and specialty pharmacy with patient engagement tools, medication adherence platforms, and population health analytics. EnlivenHealth's adherence programs have demonstrated measurable improvements in medication synchronization rates and 90-day fill compliance across participating pharmacies.

Omnicell's Central Pharmacy Automation portfolio includes the XR2 Automated Central Pharmacy System, which uses robotic picking, RFID verification, and automated packaging to process medication orders with near-zero error rates. Facilities using XR2 have reported labor savings of up to 50% in central pharmacy dispensing workflows compared to manual processes.

For 340B compliance, Omnicell offers split-billing and contract pharmacy management tools integrated directly into dispensing workflows, enabling covered entities to capture eligible savings while maintaining audit-ready documentation. The 340B solution supports both in-house and contract pharmacy arrangements with automated accumulator tracking.

Integration capabilities span all major EHR platforms including Epic, Cerner (now Oracle Health), and MEDITECH, with HL7 and FHIR-based interfaces enabling bidirectional data exchange for order verification, administration documentation, and clinical decision support. Omnicell's open API architecture also supports connections with wholesaler ordering systems, GPO contract databases, and state prescription drug monitoring programs (PDMPs).

Omnicell reported approximately $1.1 billion in annual revenue for fiscal year 2024, with a growing proportion attributed to recurring SaaS and service revenue as the company transitions from capital equipment sales toward a subscription-based model under its Autonomous Pharmacy roadmap.